𝔖 Bobbio Scriptorium
✦   LIBER   ✦

BEHAVIORAL DISTURBANCES IN ALZHEIMER’S DISEASE: A NON-PHARMACOLOGICAL THERAPEUTIC APPROACH

✍ Scribed by A. SILVESTRI; G. ROSANO; G. ZANNINO; F. RICCA; V. MARIGLIANO; M. FINI

Publisher
Elsevier Science
Year
2004
Tongue
English
Weight
456 KB
Volume
38
Category
Article
ISSN
0167-4943

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Non-cognitive disturbances in alzheimer'
Non-cognitive disturbances in alzheimer's disease
✍ Brian A. Lawlor 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 409 KB 👁 1 views

Although the hallmark of Alzheimer's disease (AD) is memory loss, behavioural and psychiatric disturbances are common and often pose the greatest problems for carers and patients. Modifying behavioural disturbance in AD sufferers can delay institutionalization and improve the quality of life of pati

Giving up driving in Alzheimer's disease
Giving up driving in Alzheimer's disease—an integrative therapeutic approach
✍ Dr. Marcel Bahro; Earle Silber; Paulette Box; Trey Sunderland 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 372 KB

For patients with Alzheimer's disease (AD), a recommendation to stop operating a motor vehicle can be a serious event complicated by a loss of self-esteem and personal dignity. Patients are often relwtant to give up an activity so essential, both practically and symbolically, to independent living.

Elevated glutathione as a therapeutic st
Elevated glutathione as a therapeutic strategy in Alzheimer's disease
✍ D. Allan Butterfield; Chava B. Pocernich; Jennifer Drake 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB 👁 2 views

## Abstract Alzheimer's disease (AD) is characterized by progressive loss of memory and cognition. Our laboratory and many others have shown that the AD brain is under extensive oxidative stress. Numerous therapeutic approaches to AD therapy have been hypothesized. Among these are exogenous antioxi

Gender, aggression and serotonergic func
Gender, aggression and serotonergic function are associated with response to sertraline for behavioral disturbances in Alzheimer's disease
✍ Krista L. Lanctôt; Nathan Herrmann; Robert van Reekum; Goran Eryavec; Claudio A. 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB 👁 1 views

## Background: Indications for serotonergic medications in the treatment of behavioral disorders associated with alzheimer's disease (ad) remain to be established. ## Method: Sertraline (100 mg od) was evaluated in a double-blind, randomized, placebo-controlled cross-over study in 22 nondepressed

Behavioral profile of Alzheimer's diseas
Behavioral profile of Alzheimer's disease in Chinese elderly – a validation study of the Chinese version of the Alzheimer's disease behavioral pathology rating scale
✍ Linda C. W. Lam; W. K. Tang; Vivian Leung; Helen F. K. Chiu 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB 👁 1 views

## Abstract ## Objectives This study aims to examine the psychometric properties of the Chinese version of the Alzheimer's disease behavioral pathology rating scale (CBehave‐AD) and the behavioral profile of Chinese patients with AD. ## Methods Seventy‐one subjects with NINCDS‐ADRDA diagnosis of